Molecular cloning and characterisation of the gene encoding the murine D4 dopamine receptor  by Simone Fishburn, C. et al.
FFBS 15240 FEBS Letters 361 (1995) 215-219 
Molecular cloning and characterisation of the gene encoding the murine 
D 4 dopamine receptor 
C. Simone Fishburn, Shari Carmon, Sara Fuchs* 
Department ofChemical Immunology, The Weizmann I stitute of Science, Rehovot 76100, Israel 
Received 12 January 1995; revised version received 7 February 1995 
Abstract The murine D 4 dopamine receptor was isolated from 
a murine genomic DNA library. The receptor's entire coding 
region was contained within a 6 kb EcoRI genomic fragment, 
indicating that the murine D4 receptor gene is significantly 
smaller than the corresponding D2 and D3 receptor genes, the 
coding regions of which each stretch over 30 kb. The murine 1)4 
rt~eptor gene has three introns and four exons, in common with 
the rat and human D4 receptor genes. RT-PCR on mRNA from 
different brain regions shows that the ])4 receptor mRNA is 
expressed in various areas of the brain, with some differences 
from the rat and human receptor homologues. 
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1 Introduction 
Dopamine receptors have been associated with a number of 
r;europathological disorders, and represent the primary thera- 
peutic target in schizophrenia, Parkinson's disease and Hunt- 
iagton's chorea [1,2]. Receptors of the D2** subclass have 
s aown a particular connection with these disorders, since many 
~f the drugs used in their treatment act as specific agonists or 
~ntagonists at these receptors [3]. Molecular cloning studies 
I~ave thus far ascribed three subtypes to this class, termed the 
l )2, D3 and D 4 receptors, and these receptors are found to bind 
range of antipsychotic drugs with differing orders of affinity 
~ reviewed in [4,5]). While typical neuroleptics, uch as haloperi- 
ol, bind all three subtypes with a dissociation constant in the 
~ anomolar ange, the atypical neuroleptic clozapine binds the 
1)4 subtype more potently than the D2 and D 3 subtypes by one 
, ~rder of magnitude [6]. The main drawback of the use of typical 
~euroleptics in psychotherapy is that they frequently lead to the 
,kevelopment of tardive dyskinesia, a hyperkinetic movement 
disorder similar to Parkinson's disease. Since treatment of 
,,chizophrenic patients with clozapine is generally not accompa- 
~ded by these side effects, its selectivity and high affinity for the 
)4 receptor have aroused much interest in this receptor sub- 
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'*To avoid confusion of nomenclature, the terms D1 and D2 shall be 
ased to refer to the two classes of dopamine r ceptor originally defined 
by pharmacological and biochemical studies at the protein level. The 
cloned receptor subtypes, defined by their DNA sequence, shall be 
denoted by a subscript, e.g. D2. 
type. Moreover, following the cloning of the human D 4 dopam- 
ine receptor, it was found to exist in several polymorphic forms 
in the human population [7], further fuelling interest in this 
receptor subtype. 
Dopamine receptors all belong to the superfamily of G pro- 
tein-linked receptors, and their sequences therefore display the 
predicted seven transmembrane topology. D2-type dopamine 
receptors, however, are unusual in this family, as they are 
encoded by genes containing introns within the coding region, 
in contrast to D 1-type receptors and the majority of G protein- 
linked receptor genes which are encoded by intronless genes [8], 
The presence of introns in the coding region has been shown, 
for the D2 and D3 receptor subtypes, to give rise to alternative 
splicing in the region of the putative third cytoplasmic loop, 
generating 'long' and 'short' functional receptor isoforms [9- 
12]. Previously, we performed a detailed analysis of the struc- 
tural organisation of the murine D 3 dopamine receptor gene 
[13], and showed that, like the murine D2 receptor gene [14], it 
contains ix introns within its coding region, one more than the 
five introns reported for the homologous human D3 receptor 
gene [15]. The D 4 receptor gene has been isolated from human 
and rat sources and found to differ from the D2 and D 3 recep- 
tors in the number of introns and exons [6,16]. In order to 
characterise further the functional differences and evolutionary 
relationship between the various D2-type dopamine receptors, 
we have cloned and sequenced the murine D4 dopamine recep- 
tor gene, and have examined its intron-exon organisation. 
2. Materials and methods 
2.1. Materials 
All molecular biology reagents, unless stated otherwise, were pur- 
chased from Boehringer (Mannheim Germany). PCR on cDNA was 
performed using Taq polymerase (Promega). Oligonucleotides and 
PCR primers were prepared by the laboratory of oligonucleotide syn- 
thesis, and sequence r actions were performed on both strands of DNA 
by the DNA sequencing facility, both at the Weizmann Institute of 
Science. Nitrocellulose membranes were purchased from Schleicher and 
Schuell, and [y-nP]dATP (3,000 Ci/mmol) was purchased from Amer- 
sham. 
2.2. Isolation of the murine D 4 dopamine receptor gene 
A 2FixlI 129/sv mouse genomic library (Stratagene) was screened 
using 5' labelled oligonucleotides: (1) 5'-CCACGGAAAGTGGCCC- 
AGTAAAGC-3' (rat D4 739-761]); (2) 5'-TTCCTGATGTGTTGGA- 
CGCCTTTC-3' (rat D 4 1091-1114); (3) 5'-CAACAGCCCACCGTC- 
ACCAGTAGCGCTGCTGTTCCCCAT-3' (rat D4 131 169); (4) 5'- 
AGCAGCGGAGACGAAGAGTCTTGCGGAAGACACTTC- 3'
( ra t  D 4 1251-1285); based on the rat D4 receptor sequence [16]. Probe 
labelling, hybridisation and washing conditions were performed ac- 
cording to standard procedures [17]. DNA from positive clones was 
isolated using Lambda Maxi-prep columns (Qiagen), and inserts were 
excised using the enzyme NotI. A 6 kb EcoRI fragment from a positive 
clone was subcloned into the vector pBluescript (Stratagene) for se- 
quence analysis. 
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2.3. Analysis of  D 4 receptor mRNA distribution 
For analysis of the tissue distribution of the murine D 4 receptor, total 
RNA was prepared from different murine tissues and brain regions 
using the guanidium thiocyanate-CsC1 method [18]. RT-PCR was per- 
formed using primers based on sequences from the receptor's putative 
third cytoplasmic loop: (5) 5'-GCCACTTTCCGCGGCCTGC- 
3&prime (mouse D4 627-645); (6) 5'-GGACTCTCA-TTGCCTTGC-3' 
(mouse D 4 929 945). PCR products were electrophoresed on agarose 
gels and Southern blotted as described previously [12]. 
3. Results 
In order to clone the murine form of the D 4 dopamine recep- 
tor and examine its genomic organisation, we screened a mouse 
(129/sv) genomic library using oligonucleotide probes 1 and 2, 
based on the sequence of the third cytoplasmic loop of the rat 
D 4 receptor [16], since this is the region found to differ most 
between the respective dopamine receptors. Six clones were 
isolated, one of which also hybridised with oligonucleotide 
probes 3 and 4, derived from the amino- and carboxy-termini 
of the rat D4 receptor, respectively, suggesting that the full 
coding region of the murine D4 receptor was present. Restric- 
tion digestion and Southern blotting of this clone revealed a 
6 kb EcoRI fragment the hybridisation profile of which sug- 
gested it contained the receptor's entire coding region. This 
fragment was subcloned into the vector pBluescript, and its 
identity as the murine form of the D4 dopamine receptor was 
confirmed by sequence analysis. 
The murine D 4 dopamine receptor is a protein of 387 amino 
acids, the sequence of which predicts the seven transmembrane 
topology expected for members of the G protein-linked recep- 
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TCC 60 
S 20 
CTG 120 
L 
CGC 180 
R 60 
C~ 240 
L 
CTG 300 
L I00 
ATC 360 
r 
TAC 420 
Y 140 
GCG 480 
A ~t4 
TGC 540 
C 180 
TGT 600 
C 
GCC 660 
A 220 
GTG 720 
V 240 
CGG 780 
R 260 
CCC 840 
P 280 
AGG 900 
R 300 
GTC 960 
V 
TGT 1020 
C 340 
AAC 1080 
N 
CGC 1140 
R 380 
Fig. 1. Sequence of the coding region of the murine D4 dopamine receptor. The deduced amino acid sequence ispresented using the one-letter code. 
The seven putative transmembrane domains (TM1- TM7) are underlined. Positions of introns are shown by arrows. The potential N-linked 
glycosylation site is marked by an asterisk, and the putative site for phosphorylation by protein kinase A is marked by a filled circle. This sequence 
has been submitted to the Genbank and assigned the accession umber U19880. 
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P I E - -  EcoRI 
S - -  Sinai 
I< - -  Kpnl 
[ ~g. 2. Structure of the murine D 4 dopamine receptor gene. The top 
shows the proposed arrangement of he transmembrane segments (dark 
b*:~xes) inthe receptor. Receptor regions are connected toexons repre- 
s~.nted on the gene map below. Exons within the coding region are 
shown by white boxes, exons from the 5' and 3' non-translated regions 
axe shown by hatched boxes. Introns are represented by a solid line. The 
g~.'ne map is drawn to scale as indicated. Restriction sites are indicated. 
t ,  EcoRI; K, Kpnl; P, PstI; S, Srnal. 
tor superfamily (Fig. 1). In common with the D2 and D 3 recep- 
tors, the D 4 subtype displays a putative N-linked glycosylation 
s~te in the extracellular amino-terminus, and a consensus se- 
t!uence for phosphorylation in the third cytoplasmic loop, both 
~.f which are conserved in the human and rat forms of the 
~eceptor. The murine D4 receptor is highly homologous to the 
rat receptor [16], but has an extra two residues (VQ) at the end 
t,f the second transmembrane domain, which are also present 
ia the human D4 receptor [6]. This discrepancy is due to the fact 
i nat the sequence GTCCAG immediately following intron 1 
was interpreted for the mouse and human receptors as the 
beginning of exon 2, representing the residues Val and Gin, 
whereas for the rat receptor they were seen as part of the intron. 
Since in all three species the sequence ofthis section was derived 
I tom a genomic rather than a cDNA clone, either interpretation 
t:ould be correct, as the consensus sequence for an acceptor site 
ir/CH NCAG) [19] is conserved in both cases. However, se- 
quence comparison with the murine D2 and D 3 dopamine re- 
ceptors shows them to have an intron at exactly the same 
position as that determined here [13, 14], supporting the inter- 
!~retation that the GTCCAG sequence r presents he beginning 
,~f the second exon, and encodes the residues valine and glutam- 
~ne. 
We have used this genomic lone to examine the structural 
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organisation of the murine D4 receptor gene. As is shown in 
Fig. 2, this gene contains three introns and four exons in the 
coding region, in common with the rat and human D4 receptor 
genes. Introns 1, 2 and 3 in the murine D 4 receptor gene are 
located at identical positions to introns 1, 2 and 6 in the murine 
D 2 and D 3 receptor genes, supporting a common evolutionary 
origin [13,14]. However, these introns are significantly smaller 
than their parallels in the other D2-1ike dopamine receptor 
genes, accounting for the comparatively small size of the D 4 
receptor gene. As can be seen from Table 1, the GT:AG consen- 
sus for intron-exon boundaries i  conserved for introns 1 and 
2, at both donor and acceptor sites, but varies lightly for intron 
3, as has been reported for the corresponding introns in the 
human D 4 receptor gene [6]. 
In order to examine the tissue distribution of the murine D 4 
dopamine receptor, PCR was performed on different murine 
tissues and brain regions using primers (5 and 6) derived from 
the region of the third cytoplasmic loop. Southern analysis of 
the PCR products is shown in Fig. 3. The murine D 4 receptor 
mRNA is present in the olfactory bulb, hypothalamus, olfac- 
tory tubercle, brainstem and striatum, in common with the rat 
and monkey homologues ]6,16]. Low levels of receptor mRNA 
were also detected in cortex (data not shown). In contrast with 
the rat and monkey, however, a relatively strong signal is ob- 
tained in the murine cerebellum. No signal could be detected 
in murine heart issue (data not shown), unlike the rat heart in 
which relatively high levels of D 4 receptor mRNA have been 
reported [16]. 
4. Discussion 
In this study we have cloned and sequenced the murine D 4 
dopamine receptor gene, and have analysed its intron-exon 
organisation. The structural organisation of the murine D4 
receptor gene shows it to have three introns and four exons 
within the coding region, at analagous positions to those in the 
human and rat D 4 receptors [6,16]. The presence of the entire 
coding region within a 6 kb EcoRI fragment demonstrates that 
the murine D, receptor gene is significantly smaller than the 
murine D2 and D3 receptor genes, whose coding regions each 
extend over more than 30 kb [13,14]. This is in accordance with 
the human and rat D 4 receptor genes, which were found to be 
contained within 5 kb and 3.5 kb restriction fragments, respec- 
tively. 
The murine D2 and D 3 receptors how directly analogous 
gene organisations, and are closer to each other than to the 
murine D 4 receptor, which differs from them by the absence of 
Fable 1 
:.xon-intron boundaries of murine D 4 receptor gene 
ntron Donor Acceptor Position of Intron size Size of Size of 
~o. intron a corresponding corresponding 
human D4 mur ine  D 3 
intron b intron c 
[ TCCGAG gtgagcctcg tgcgtgaccag GTCCAG 275 -2000 bp ~2000bp >12 kb 
GGACAG gtgggtaccc tgctcctctag GTTCGT 389 88 bp 103 bp 18 kb 
TAGTCG gtgggatcct cccatccccag GGGCCT 1022 174 bp 92 bp 1.3 kb 
Upper case letters denote xon sequences, lower case letters denote intron sequences. 
'Number refers to position in murine D4 receptor cDNA sequence (Fig. 1). 
'Van Tol et al. [6]. 
Park et al. [13]. 
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introns following the fourth transmembrane domain and in the 
putative third cytoplasmic loop [13,14]. Nevertheless, the struc- 
tural organisation of the D 4 receptor gene remains closer to the 
D2 and D 3 receptors than to any other receptor gene thus far 
cloned, supporting the idea that all three genes may have 
evolved from a common ancestor gene by successive gene dupli- 
cation events. The presence or absence of introns in the coding 
region represents one of the fundamental differences between 
the D2-type and the Dl-type receptor genes. While most G 
protein-linked receptors thus far studied are encoded by intron- 
less genes, there is a growing number of receptors in this family 
which display introns in the coding region, suggesting that there 
may be subfamilies of receptors in this superfamily. Within the 
class of intron-containing G protein-linked receptors, the loca- 
tion of the introns with respect o the seven transmembrane 
domains is found to coincide among different neurotransmitter 
and hormone receptors [20]. It has been postulated that the 
intron-exon organisation of such G protein-linked receptors 
may signify an arrangement according to discrete functional 
domains, suggesting that gene conversion and duplication 
events may have taken place to generate structurally similar 
and functionally different receptors. 
Sequence comparison of the murine D 4 subtype with the 
human and rat homologues shows that at the nucleotide level, 
the mouse D4 receptor displays 79% and 93% homology with 
the human and rat receptors, respectively. The amino acid 
sequence of the murine D 4 receptor displays 80% and 95% 
homology with the human and rat D 4 receptors, respectively, 
the most conserved regions being observed in the transmem- 
brane domains, consistent with the proposal that these domains 
form the ligand-binding site. The least conserved regions be- 
tween the murine and human forms of the D 4 receptor are 
found in the amino-terminal domain (76% identity) and the 
putative third cytoplasmic loop (72% identity). The diversity 
between the murine and human D4 receptors in the third cyto- 
plasmic loop is significantly greater than that observed for the 
D2 and D3 receptors in this region, which show 93% and 83% 
sequence identity, respectively, between these species. 
The human D 4 receptor has been found to exist in several 
polymorphic variations, which differ by the number of repeat 
units (composed of 16 amino acids), also located in the third 
cytoplasmic loop, and these polymorphic variants are found to 
display slightly different pharmacological properties [7]. If the 
human D 4 receptor's polymorphic variants underlie different 
D4-related behavioural properties in the human population, 
OT HT OB ST BS CB SP 
I 
mouse 1 MGNSSATEDC4~LLAGRGP-- -ESLGTGAGLC~GAAALV~LIGLVLA 47 
I I l . l . . : . : [ l [ l l l l ]  .I I . : l l l : l ] . l [ l l l l l l ] l l l l  I I I  
human 1 MGNRSTADADGLLAGRGPAAGASAGASAGLAG~)GAAALVGGVLLIGAVLA 50 
II 
mouse 48 GNSLVCVSVA~ERTLQTPTN~YFI"VSLAAADLLLAVLVI~PLFVYSEVQ~V 97 
llllllIlil~.ll.lill IIl lllllJilfllil:ililrlllllli~ll. 
human 51 GNSLVCVSV;%~ERALQTPTh~SFIVSLAAADLLLALLVLPLFVYSEV~3A i00 
III 
mouse 98 WLLSPR]~CDTLMAMDVMLCTASIFNLCAISVDR~AVTVPLRYNQQGQC- 146 
IlI[II~ll,IIilllIIlt llilllIIlllll~IIll.llllli.ll.: 
human i01 WLLSPR~,CDALMAMDVMLCTASIFNLCAISVDR~VAVAVPLRYNRQGGSR 150 
IV 
mouse 147 ~QLLLIAATWLLSAAVASPVVCGLh,(DVPGRDPAVCCLEI~DYAA/YSSVCS 195 
[JI I I1 :11 I I I l l l l r . l l : l l l l l l l . l l l l ] l l  I I : [ l l l l l l l l l [ I  
human 151 I~LLLIGA~LSAAVAAPVLCGLI'hIDVRGRDPAVCRLEE~DYVVYSSVCS 200 
V 
mouse 196 FFLPCP~LLY~TFRGLRRWEAARHTKLHSRAPRRPSGPGPPVSDP--  243 
llllillllIIIIIllIIll.ill.li:.lil:IIIJlilillll ..I 
human 201 FFLPCPLMLLLY~IATFRGLQRWEVARRA/~LHGRApRRPSGPGPPSPTP_P_A_ 250 
mouse 244 ---TQGPFFPDCPPPLPSLRTSPSDSSRPESELSQRPCSPGCLLADAALP 290 
.1:1 I I1 :11 I :1 . . .1 : :1 .  I . I .  : . f i l l  
human 251 PRLPODPCGPDCAPPAPGLPPDPCGSN .......... ~APPDA~P 290 
VI 
mouse 291 QPPEPSSRRRRGAKITGRER~PVVVGAFLVCWTPFFVV'H ITRA~ 340 
.... B .IPll flrlllllJlfl~lllllillll:illlilillJl.flll 
human 291 PQTPPQTRRRRRAKITGRERKAMI~LFVVVGAFLLCWTPFFVVHITQAI~C 340 
VII 
mouse 341 PACFVS~PRLVSAV'I~gLGYirNSALNPIIY'I'~FNAEFRSVFRKTLRLRC 387 
Irl J.llil1111 llllll illlIl:It ll:lllJil.llIi.ll I 
human 341 PACSV~[PRLVSAV'I'WLGYVNSALNPVIYq~FNAEFRNVFRKALRACC 387 
Fig. 4. Sequence alignment of the mouse and human D4 dopamine 
receptors. Transmembrane domains are boxed and indicated inRoman 
numerals. The 16 amino acid repeat, present twice, in the human recep- 
tor is denoted by a solid black line. 
this region of diversity may represent a functional domain 
which is responsible for these different properties. Fig. 4 shows 
a comparison of the murine receptor with the human D4 recep- 
tor variant containing two repeat units (D4.2), which is the 
closest form to the murine and rat receptors. It can be seen from 
this comparison that the area of greatest diversity between the 
murine and human D4 receptors overlaps with the sequence 
representing the two 16 amino acid repeats in the human recep- 
tor (Fig. 4, bold underline). Given that complex behaviour and 
its molecular basis may be expected to differ between mice and 
humans, the weak degree of conservation among these residues 
between the species upports the notion that behavioural prop- 
erties of the D4 receptor may relate to this functional domain. 
It has been suggested that the low levels of D4 receptor 
mRNA may not directly reflect the level of receptor protein, 
and that higher levels of D 4 receptor protein are detected than 
would be predicted from the mRNA levels [21]. The availability 
of the murine D 4 receptor sequence nables us to develop anti- 
peptide antibodies specific for the murine D4 dopamine recep- 
tor, which can be used in studies to determine the distribution 
and properties of the D4 receptor protein in the mouse. Further- 
more, the current movement towards analysis of a protein's 
role by gene targetting techniques generally uses the mouse as 
the species of choice [22]. Thus, it may be of particular benefit 
to have information regarding the characteristic features of the 
murine form of the D 4 dopamine receptor. 
Fig. 3. Tissue distribution of the murine D 4 dopamine r ceptor. South- 
ern analysis was performed on PCR products amplified using primers 
5 and 6 from different mouse tissues, as described in section 2. OB, 
olfactory bulb; HT, hypothalamus; OT, olfactory tubercle; BS, brain- 
stem; ST, striatum; CB, cerebellum; SP, spleen. 
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